[Report on 5-years' Experience with Dimethylbiguanide (metformin, Glucophage) in Diabetic Therapy]
Overview
Authors
Affiliations
Metformin and the Liver: Unlocking the Full Therapeutic Potential.
Perazza F, Leoni L, Colosimo S, Musio A, Bocedi G, DAvino M Metabolites. 2024; 14(4).
PMID: 38668314 PMC: 11052067. DOI: 10.3390/metabo14040186.
Understanding the action mechanisms of metformin in the gastrointestinal tract.
Cheng M, Ren L, Jia X, Wang J, Cong B Front Pharmacol. 2024; 15:1347047.
PMID: 38617792 PMC: 11010946. DOI: 10.3389/fphar.2024.1347047.
Goglia U, Hasballa I, Teti C, Boschetti M, Ferone D, Albertelli M Cancers (Basel). 2024; 16(7).
PMID: 38610965 PMC: 11011026. DOI: 10.3390/cancers16071287.
Metformin therapy in pediatric type 2 diabetes mellitus and its comorbidities: A review.
Alfaraidi H, Samaan M Front Endocrinol (Lausanne). 2023; 13:1072879.
PMID: 36814831 PMC: 9939509. DOI: 10.3389/fendo.2022.1072879.
Cellular and Molecular Mechanisms of Metformin Action.
LaMoia T, Shulman G Endocr Rev. 2020; 42(1):77-96.
PMID: 32897388 PMC: 7846086. DOI: 10.1210/endrev/bnaa023.